Connection
Eduardo Davila to Antineoplastic Agents
This is a "connection" page, showing publications Eduardo Davila has written about Antineoplastic Agents.
|
|
Connection Strength |
|
 |
|
 |
|
0.425 |
|
|
|
-
Li Z, Younger K, Gartenhaus R, Joseph AM, Hu F, Baer MR, Brown P, Davila E. Inhibition of IRAK1/4 sensitizes T cell acute lymphoblastic leukemia to chemotherapies. J Clin Invest. 2015 Mar 02; 125(3):1081-97.
Score: 0.230
-
Tamada K, Geng D, Sakoda Y, Bansal N, Srivastava R, Li Z, Davila E. Redirecting gene-modified T cells toward various cancer types using tagged antibodies. Clin Cancer Res. 2012 Dec 01; 18(23):6436-45.
Score: 0.195